Antigrowth Effect of Some Inhibitors of Polyamine Synthesis on Transplantable Prostate Cancer

Abstract
Inhibitors of polyamine synthesis were tested for therapeutic effectiveness on transplantable prostate cancer [in rats]. Inhibition of ornithine decarboxylase or S-adenosyl-L-methionine decarboxylase (AMDC) or .alpha.-difluoromethylornithine (DFMO) or methylglyoxal-bis[guanylhydrazone] (MGBG), respectively, was associated with significant antitumor effect. The combination of DFMO with MGBG was not only more effective but no more toxic than MGBG alone. Combination of MGBG with 9-B-D-arabinofuranosyladenine, an indirect effector of SAMDC, failed to increase therapeutic effectiveness of MGBG.